Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response

NEXT STORY
Calithera Biosciences Announces Telaglenastat KEAPSAKE Trial in Progress Abstract Accepted for Presentation at ASCO20 Virtual Annual Meeting
PREV STORY
ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dementia and other neurodegenerative diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Clinical Trial Market Revenue to Cross $69.94 by 2027 Global Industry Size, Share, Trends, COVID-19 Analysis and Technology Advancements by Clinipace, Novo Nordisk, Pfizer, Sanofi, F. Hoffmann-La Roche Ltd, Alcami Corporation and Accell Clinical Research

author_avatar
NASDAQ Market News

Eledon Pharmaceuticals CEO David-Alexandre C. Gros, M.D., to Present at CareDx Virtual Transplant Innovation Day during ASN Kidney Week 2021

author_avatar
NASDAQ Market News

Albireo Announces Bylvay® (odevixibat) Now Available in Germany

author_avatar
NASDAQ Market News